Aminoglikozid Kullanımına Bağlı Gelişen ABY
Journal Name:
- Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi
Publication Year:
- 2006
Author Name | University of Author | Faculty of Author |
---|---|---|
REFERENCES
1. Humes HD. Aminoglycoside nephrotoxicity. Kidney Int 1988;33:900.
2. Moestrup SK, Cui S, Vorum H, et al. Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J Clin Invest 1995;96:1404.
3. Laurent G, Kishore BK, Tulkens PM. Aminoglycoside-indu-ced renal phospholipidosis and nephrotoxicity. Biochem Pharmacol 1990;40:2383-2392.
4. Laurent G, Maldague P, Carlier MB, Tulkens P. Increased re¬nal DNA synthesis in vivo after administration of low doses of gentamicin in rats. Antimicrob Agents Chemother 1983;24: 586-593.
5. Houghton DC, English J, Bennett WM. Chronic tubulointerstiti-al nephritis and renal insufficiency associated with long-term "subtherapeutic" gentamicin. J Lab Clin Med 1988;112:694.
6. Smith CR, Lipsky JJ, Oetty BG, et al. Double-blind compari¬son of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med 1980;302:1106.
7. Barza M, Ioannidis JP, Cappelleri JC, Lau J. Single or multip¬le daily doses of aminoglycosides: A meta-analysis. BMJ
1996;312:338.